http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111481565-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-739 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-739 |
| filingDate | 2019-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111481565-B |
| titleOfInvention | Use of lipopolysaccharide of paradisella gordonii for pharmaceutical composition for inhibiting inflammatory reaction |
| abstract | The invention relates to the field of microbial products, in particular to application of lipopolysaccharide of paradisella gasseri in preparing a medicinal composition for inhibiting inflammatory reaction. The invention provides an application of lipopolysaccharide of parabacter gordonii in preparing a pharmaceutical composition for inhibiting inflammatory reaction, wherein the lipopolysaccharide of parabacter gordonii can effectively inhibit immune reaction of peripheral blood mononuclear cells, macrophages and/or B cells caused by pathogenic lipopolysaccharide, so that the lipopolysaccharide can be effectively used for inhibiting inflammatory reaction and preparing related pharmaceutical compositions. |
| priorityDate | 2019-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 90.